Literature DB >> 24859553

The utility of online haemodiafiltration in methotrexate poisoning.

Mohamed Said Abdelsalam1, Mohammed Mahdi Althaf2, Osman Alfurayh2, Irfan Maghfoor3.   

Abstract

Summary We report a case of a 56-year-old woman with a high-grade diffuse large B-cell lymphoma who unexpectedly developed toxic plasma levels of methotrexate (MTX) following the first cycle of rituximab-cyclophosphamide, hydroxydanorubicin, oncovin, prednisolone (R-CHOP) with a high-dose MTX chemotherapy protocol. She also developed non-oliguric acute kidney injury secondary to MTX nephrotoxicity. We elected to treat her with online-haemodiafiltration (HDF) and this proved to be efficient with a dramatic response. Rapid clearance of MTX to therapeutic levels was possible within three sessions. Prompt therapy with high-volume online-HDF is an effective choice for rapid MTX clearance and swift reversal of MTX nephrotoxicity. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24859553      PMCID： PMC4039908          DOI： 10.1136/bcr-2014-203530

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  19 in total

1.  Letter: Limitations of methotrexate and citrovorum-factor treatments.

Authors:  E Frei; N J Jaffe; S Pitman
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

2.  Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma.

Authors:  D J Grimes; M R Bowles; J A Buttsworth; D B Thomson; P J Ravenscroft; P F Nixon; R F Whiting; S M Pond
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

3.  Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.

Authors:  W E Evans; C B Pratt; R H Taylor; L F Barker; W R Crom
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  A case of methotrexate-induced acute renal failure successfully treated with plasma perfusion and sequential hemodialysis.

Authors:  K Kawabata; H Makino; Y Nagake; H Tokioka; M Matsumi; Y Morita; K Ota; K Shikata; Z Ota
Journal:  Nephron       Date:  1995       Impact factor: 2.847

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion.

Authors:  M V Relling; F B Stapleton; J Ochs; D P Jones; W Meyer; I W Wainer; W R Crom; C P McKay; W E Evans
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

Review 7.  Tumour lysis syndrome: new therapeutic strategies and classification.

Authors:  Mitchell S Cairo; Michael Bishop
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

8.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

9.  Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.

Authors:  Stefan Schwartz; Klaus Borner; Krystina Müller; Peter Martus; Lars Fischer; Agnieszka Korfel; Timothy Auton; Eckhard Thiel
Journal:  Oncologist       Date:  2007-11

10.  Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.

Authors:  A Mary Vilay; Bruce A Mueller; Hilary Haines; Jeffery A Alten; David J Askenazi
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705
View more
  1 in total

1.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.